Do analysts recommend USNA or ODD?

ODDITY Tech has a consensus target price of $27.23, suggesting a potential upside of 50.10%. Given ODDITY Tech's stronger consensus rating and higher probable upside, analysts plainly believe ODDITY Tech is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 ODDITY Tech 4 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.71

Do analysts recommend USNA or HNST?

Honest has a consensus price target of $4.84, suggesting a potential downside of 9.36%. Given Honest's stronger consensus rating and higher probable upside, analysts plainly believe Honest is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Honest 2 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.22

Do analysts recommend USNA or BWMX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Betterware de Mexico SAPI de C 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Do analysts recommend PRE or USNA?

Prenetics Global currently has a consensus target price of $34.80, suggesting a potential upside of 58.04%. Given Prenetics Global's stronger consensus rating and higher probable upside, equities analysts clearly believe Prenetics Global is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prenetics Global 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67 USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate USNA or NAGE?

Niagen Bioscience has a consensus price target of $10.33, suggesting a potential upside of 244.44%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Niagen Bioscience is more favorable than USANA Health Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score USANA Health Sciences 2 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Niagen Bioscience 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00

USANA Health Sciences (USNA) Competitors

$14.71 -0.19 (-1.28%)

Closing price 09/16/2026 03:59 PM Eastern

Extended Trading

$14.71 0.00 (0.00%)

As of 04:02 AM Eastern

Compare

USNA vs. ODD, HNST, BWMX, PRE, and NAGE

Should you buy USANA Health Sciences stock or one of its competitors? USANA Health Sciences's main competitors and comparable companies include ODDITY Tech (ODD), Honest (HNST), Betterware de Mexico SAPI de C (BWMX), Prenetics Global (PRE), and Niagen Bioscience (NAGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does USANA Health Sciences compare to ODDITY Tech?

USANA Health Sciences (NYSE:USNA) and ODDITY Tech (NASDAQ:ODD) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 35.9% of ODDITY Tech shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

ODDITY Tech has a net margin of 2.23% compared to USANA Health Sciences' net margin of -2.43%. USANA Health Sciences' return on equity of 3.41% beat ODDITY Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
ODDITY Tech	2.23%	2.58%	0.80%

ODDITY Tech has a consensus target price of $27.23, suggesting a potential upside of 50.10%. Given ODDITY Tech's stronger consensus rating and higher probable upside, analysts plainly believe ODDITY Tech is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ODDITY Tech	4 Sell rating(s)	10 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.71

In the previous week, ODDITY Tech had 25 more articles in the media than USANA Health Sciences. MarketBeat recorded 25 mentions for ODDITY Tech and 0 mentions for USANA Health Sciences. ODDITY Tech's average media sentiment score of 0.66 beat USANA Health Sciences' score of 0.00 indicating that ODDITY Tech is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
ODDITY Tech	Positive

USANA Health Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, ODDITY Tech has a beta of 2.38, indicating that its share price is 138% more volatile than the broader market.

ODDITY Tech has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than ODDITY Tech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A
ODDITY Tech	$809.84M	1.29	$110.75M	$0.24	75.58

Summary

ODDITY Tech beats USANA Health Sciences on 10 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Honest?

USANA Health Sciences (NYSE:USNA) and Honest (NASDAQ:HNST) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

USANA Health Sciences has a net margin of -2.43% compared to Honest's net margin of -3.56%. Honest's return on equity of 4.31% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Honest	-3.56%	4.31%	3.33%

Honest has a consensus price target of $4.84, suggesting a potential downside of 9.36%. Given Honest's stronger consensus rating and higher probable upside, analysts plainly believe Honest is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Honest	2 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.22

In the previous week, Honest had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 1 mentions for Honest and 0 mentions for USANA Health Sciences. Honest's average media sentiment score of 1.92 beat USANA Health Sciences' score of 0.00 indicating that Honest is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
Honest	Very Positive

USANA Health Sciences has higher revenue and earnings than Honest. Honest is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A
Honest	$371.32M	1.58	-$15.69M	-$0.11	N/A

USANA Health Sciences has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Honest has a beta of 2.24, indicating that its stock price is 124% more volatile than the broader market.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 45.5% of Honest shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Comparatively, 9.4% of Honest shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Honest beats USANA Health Sciences on 12 of the 17 factors compared between the two stocks.

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

USANA Health Sciences (NYSE:USNA) and Betterware de Mexico SAPI de C (NYSE:BWMX) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Betterware de Mexico SAPI de C had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 1 mentions for Betterware de Mexico SAPI de C and 0 mentions for USANA Health Sciences. Betterware de Mexico SAPI de C's average media sentiment score of 0.58 beat USANA Health Sciences' score of 0.00 indicating that Betterware de Mexico SAPI de C is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
Betterware de Mexico SAPI de C	Positive

Betterware de Mexico SAPI de C has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Betterware de Mexico SAPI de C, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A
Betterware de Mexico SAPI de C	$744M	0.87	$55.37M	$1.83	8.91

USANA Health Sciences has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Betterware de Mexico SAPI de C has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market.

54.3% of USANA Health Sciences shares are held by institutional investors. Comparatively, 12.7% of Betterware de Mexico SAPI de C shares are held by institutional investors. 0.8% of USANA Health Sciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Betterware de Mexico SAPI de C has a net margin of 8.35% compared to USANA Health Sciences' net margin of -2.43%. Betterware de Mexico SAPI de C's return on equity of 77.89% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Betterware de Mexico SAPI de C	8.35%	77.89%	11.28%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Betterware de Mexico SAPI de C	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Summary

Betterware de Mexico SAPI de C beats USANA Health Sciences on 12 of the 15 factors compared between the two stocks.

How does USANA Health Sciences compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and USANA Health Sciences (NYSE:USNA) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 54.3% of USANA Health Sciences shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by company insiders. Comparatively, 0.8% of USANA Health Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Prenetics Global had 1 more articles in the media than USANA Health Sciences. MarketBeat recorded 1 mentions for Prenetics Global and 0 mentions for USANA Health Sciences. Prenetics Global's average media sentiment score of 1.89 beat USANA Health Sciences' score of 0.00 indicating that Prenetics Global is being referred to more favorably in the media.

Company	Overall Sentiment
Prenetics Global	Very Positive
USANA Health Sciences	Neutral

Prenetics Global has a beta of 0.31, meaning that its stock price is 69% less volatile than the broader market. Comparatively, USANA Health Sciences has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market.

Prenetics Global currently has a consensus target price of $34.80, suggesting a potential upside of 58.04%. Given Prenetics Global's stronger consensus rating and higher probable upside, equities analysts clearly believe Prenetics Global is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prenetics Global	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

USANA Health Sciences has higher revenue and earnings than Prenetics Global. USANA Health Sciences is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prenetics Global	$92.39M	4.02	-$37.71M	-$4.16	N/A
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A

USANA Health Sciences has a net margin of -2.43% compared to Prenetics Global's net margin of -47.43%. USANA Health Sciences' return on equity of 3.41% beat Prenetics Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prenetics Global	-47.43%	-21.41%	-15.56%
USANA Health Sciences	-2.43%	3.41%	2.50%

Summary

Prenetics Global and USANA Health Sciences tied by winning 8 of the 16 factors compared between the two stocks.

How does USANA Health Sciences compare to Niagen Bioscience?

USANA Health Sciences (NYSE:USNA) and Niagen Bioscience (NASDAQ:NAGE) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

USANA Health Sciences has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Niagen Bioscience has a beta of 2.09, suggesting that its stock price is 109% more volatile than the broader market.

Niagen Bioscience has lower revenue, but higher earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.29	$10.76M	-$1.21	N/A
Niagen Bioscience	$129.42M	1.85	$17.38M	$0.18	16.67

Niagen Bioscience has a net margin of 12.39% compared to USANA Health Sciences' net margin of -2.43%. Niagen Bioscience's return on equity of 17.95% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.43%	3.41%	2.50%
Niagen Bioscience	12.39%	17.95%	13.17%

Niagen Bioscience has a consensus price target of $10.33, suggesting a potential upside of 244.44%. Given Niagen Bioscience's stronger consensus rating and higher possible upside, analysts clearly believe Niagen Bioscience is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Niagen Bioscience	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

In the previous week, Niagen Bioscience had 3 more articles in the media than USANA Health Sciences. MarketBeat recorded 3 mentions for Niagen Bioscience and 0 mentions for USANA Health Sciences. Niagen Bioscience's average media sentiment score of 0.81 beat USANA Health Sciences' score of 0.00 indicating that Niagen Bioscience is being referred to more favorably in the news media.

Company	Overall Sentiment
USANA Health Sciences	Neutral
Niagen Bioscience	Positive

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 15.4% of Niagen Bioscience shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Comparatively, 10.0% of Niagen Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Niagen Bioscience beats USANA Health Sciences on 15 of the 17 factors compared between the two stocks.

Get USANA Health Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

USNA vs. The Competition

Export

Metric	USANA Health Sciences	Personal Care Products Industry	Consumer Staples Sector	NYSE Exchange
Market Cap	$275.30M	$23.04B	$15.76B	$23.16B
Dividend Yield	N/A	4.58%	3.23%	3.59%
P/E Ratio	-12.16	20.11	14.03	28.22
Price / Sales	0.29	12.74	262,948.96	20.04
Price / Cash	3.61	26.58	56.73	33.71
Price / Book	0.50	2.88	4.70	4.66
Net Income	$10.76M	$1.13B	$836.60M	$1.07B
7 Day Performance	-0.72%	2.27%	-0.22%	-1.25%
1 Month Performance	15.01%	1.38%	-1.66%	-4.31%
1 Year Performance	-51.15%	-16.63%	9.68%	8.36%

USANA Health Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
USNA USANA Health Sciences	1.647 of 5 stars	$14.71 -1.3%	N/A	-51.9%	$275.30M	$925.26M	N/A	1,570
ODD ODDITY Tech	2.4987 of 5 stars	$13.75 flat	$25.75 +87.3%	-70.8%	$791.66M	$809.84M	17.41	342
HNST Honest	2.0574 of 5 stars	$5.95 flat	$4.84 -18.7%	+33.2%	$654.97M	$371.32M	N/A	190	Positive News
BWMX Betterware de Mexico SAPI de C	4.0204 of 5 stars	$15.78 +0.3%	N/A	+20.5%	$621.49M	$744M	8.62	2,441
PRE Prenetics Global	4.0202 of 5 stars	$25.44 flat	$34.80 +36.8%	+132.0%	$429.28M	$92.39M	N/A	1	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:USNA) was last updated on 9/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

USANA Health Sciences (USNA) Competitors

USNA vs. ODD, HNST, BWMX, PRE, and NAGE

How does USANA Health Sciences compare to ODDITY Tech?

Summary

How does USANA Health Sciences compare to Honest?

Summary

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Summary

How does USANA Health Sciences compare to Niagen Bioscience?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

USANA Health Sciences (USNA) Competitors

USNA vs. ODD, HNST, BWMX, PRE, and NAGE

How does USANA Health Sciences compare to ODDITY Tech?

Do institutionals and insiders hold more shares of USNA or ODD?

Is USNA or ODD more profitable?

Do analysts recommend USNA or ODD?

Does the media favor USNA or ODD?

Which has more volatility & risk, USNA or ODD?

Which has better valuation and earnings, USNA or ODD?

Summary

How does USANA Health Sciences compare to Honest?

Is USNA or HNST more profitable?

Do analysts recommend USNA or HNST?

Does the media favor USNA or HNST?

Which has higher earnings & valuation, USNA or HNST?

Which has more risk and volatility, USNA or HNST?

Do institutionals & insiders hold more shares of USNA or HNST?

Summary

How does USANA Health Sciences compare to Betterware de Mexico SAPI de C?

Does the media favor USNA or BWMX?

Which has stronger earnings and valuation, USNA or BWMX?

Which has more volatility & risk, USNA or BWMX?

Do insiders and institutionals hold more shares of USNA or BWMX?

Is USNA or BWMX more profitable?

Do analysts recommend USNA or BWMX?

Summary

How does USANA Health Sciences compare to Prenetics Global?

Do insiders & institutionals hold more shares of PRE or USNA?

Does the media prefer PRE or USNA?

Which has more risk and volatility, PRE or USNA?

Do analysts recommend PRE or USNA?

Which has stronger valuation and earnings, PRE or USNA?

Is PRE or USNA more profitable?

Summary

How does USANA Health Sciences compare to Niagen Bioscience?

Which has more risk and volatility, USNA or NAGE?

Which has higher earnings and valuation, USNA or NAGE?

Is USNA or NAGE more profitable?

Do analysts rate USNA or NAGE?

Does the media favor USNA or NAGE?

Do institutionals and insiders hold more shares of USNA or NAGE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

USNA vs. The Competition

USANA Health Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools